Skip to content
Catalyst

tirzepatidePapers

Papers about tirzepatide

papers
321
7 years, by papers

Newest first

151 to 200 of 321

Every paper here, unless its row says otherwiseIndexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

  • Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy.

    Clinical obesity2025PMID 39909715Indexed under tirzepatide in PubMed's chemical list

  • Safety and Efficacy of Tirzepatide in Solid-Organ Transplant Recipients: Experience of a Quaternary Care Center in the Middle East.

    Experimental and clinical transplantation2025PMID 39918190

  • Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.

    Endocrinology, diabetes & metabolism2025PMID 39949069

  • Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition.

    Obesity research & clinical practice2025PMID 39952885

  • Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.

    Diabetes, obesity & metabolism2025PMID 39996356

  • Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database.

    Diabetes, obesity & metabolism2025PMID 39996368Also indexed under tirzepatide as a PubMed major topic

  • Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.

    The lancet. Diabetes & endocrinology2025PMID 40031941Also indexed under tirzepatide as a PubMed major topic

  • Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients.

    Diabetes research and clinical practice2025PMID 40049522

  • Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States.

    Diabetes & metabolism2025PMID 40057019Also indexed under tirzepatide as a PubMed major topic

  • Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

    Diabetes care2025PMID 40063619

  • Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program.

    Obesity (Silver Spring, Md.)2025PMID 40074721

  • Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme.

    Diabetes, obesity & metabolism2025PMID 40083081

  • Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database.

    Diabetes, obesity & metabolism2025PMID 40084533

  • Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.

    Diabetes & metabolic syndrome2025PMID 40086043Indexed under tirzepatide in PubMed

  • Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months.

    Diabetes technology & therapeutics2025PMID 40098470

  • Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.

    Diabetes care2025PMID 40100982

  • Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi-institutional propensity score-matched study.

    Diabetes, obesity & metabolism2025PMID 40109063

  • Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.

    Journal of the American College of Cardiology2025PMID 40162940

  • Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.

    Diabetes, obesity & metabolism2025PMID 40181696Also indexed under tirzepatide as a PubMed major topic

  • Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide : A Randomized Clinical Trial.

    Annals of internal medicine2025PMID 40183678

  • Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies.

    Endocrinology, diabetes & metabolism2025PMID 40184508Indexed under tirzepatide in PubMed

  • Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis.

    Annals of Saudi medicine2025PMID 40189856Indexed under tirzepatide in PubMed

  • Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.

    Cell metabolism2025PMID 40203836

  • Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity.

    Nutrients2025PMID 40218974

  • Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study.

    Annals of internal medicine2025PMID 40228298Also indexed under tirzepatide as a PubMed major topic

  • Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study.

    Advances in therapy2025PMID 40251452

  • Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial.

    The lancet. Diabetes & endocrinology2025PMID 40318682Also indexed under tirzepatide as a PubMed major topic

  • Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison.

    Diabetes, obesity & metabolism2025PMID 40321113Indexed under tirzepatide in PubMed

  • Predicting 10-year risk of type 2 diabetes in Chinese people with overweight or obesity treated with Tirzepatide: Post hoc analysis of SURMOUNT-CN trial.

    Diabetes, obesity & metabolism2025PMID 40329666Also indexed under tirzepatide as a PubMed major topic

  • Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

    The New England journal of medicine2025PMID 40353578Indexed under tirzepatide in PubMed

  • Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial.

    Diabetes, obesity & metabolism2025PMID 40365662Also indexed under tirzepatide as a PubMed major topic

  • Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.

    Journal of the American College of Cardiology2025PMID 40368575Also indexed under tirzepatide as a PubMed major topic; tests tirzepatide

  • Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study.

    Nature communications2025PMID 40368924

  • Glucagon-Like Peptide-1 receptor agonists, dual GIP/GLP-1 receptor agonist tirzepatide and suicidal ideation and behavior: A systematic review of clinical studies and pharmacovigilance reports.

    Diabetes & metabolic syndrome2025PMID 40388845

  • Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.

    Diabetes research and clinical practice2025PMID 40412626

  • Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT-CN study.

    Obesity (Silver Spring, Md.)2025PMID 40437798

  • Comparative clinical outcomes of adults with obstructive sleep apnea and comorbid obesity receiving tirzepatide versus bariatric metabolic surgery: A Multi-Institutional propensity score matched study.

    Diabetes research and clinical practice2025PMID 40456414

  • Characteristics and Treatment Patterns of People Without Type 2 Diabetes Diagnoses Who Use Tirzepatide in the United States.

    Clinical therapeutics2025PMID 40480878

  • Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial.

    Diabetes, obesity & metabolism2025PMID 40490415

  • Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status.

    Obesity (Silver Spring, Md.)2025PMID 40491239Indexed under tirzepatide in PubMed

  • Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Obesity reviews2025PMID 40510020

  • Depression and suicide/self-injury signals for weight loss medications: A disproportionality analysis of semaglutide, liraglutide, and tirzepatide in FAERS database.

    Journal of affective disorders2025PMID 40523410Indexed under tirzepatide in PubMed's chemical list

  • Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2025PMID 40537987Indexed under tirzepatide in PubMed

  • Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide.

    Annals of internal medicine2025PMID 40550133

  • Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.

    Nature medicine2025PMID 40555748

  • A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure-Response Relationship during Treatment of Obesity with Tirzepatide.

    Clinical pharmacology and therapeutics2025PMID 40556483

  • Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World Evidence.

    Annals of the American Thoracic Society2025PMID 40590655Indexed under tirzepatide in PubMed

  • Association of tirzepatide with erectile dysfunction in people with type 2 diabetes.

    Journal of diabetes and its complications2025PMID 40614622

  • Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4.

    Diabetes2025PMID 40633089Also indexed under tirzepatide as a PubMed major topic

  • Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.

    Diabetologia2025PMID 40637847

The next 50 papers

← Previous 50